Jakob Lindberg at SEB Healthcare Seminar 2022 - Fire side chat with Christopher Uhde

Fire side chat with CEO Jakob Lindberg at SEB’s Annual Healthcare Seminar 2022

At SEB’s Annual Healthcare Seminar 2022 Jakob Lindberg, CEO Oncopeptides, participated in a fire side chat with Dr. Christopher Uhde, Pharma/Biotec equity research at SEB.

This fire side chat was recorded on November 23, 2022.

See the recording here